An evaluation study for fat metabolism improving effect by single consumption of test beverage

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000039405
• Lead Sponsor: CPCC Company Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-04-30
• Study Start: 2021-02-06
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1) Males who have previous and/or current medical history of serious disease (e.g., circulatory organs, respiratory organs, digestive organs, urinary organs and endocrine organs). 2) Males who constantly use or who can't restrict use oral medicines (related to blood pressure, fatigue and fat metabolism) having a possibility of affecting test results. 3) Males who constantly use or who can't restrict use supplements, vitamins and nutrient (related to blood pressure, blood flow, exercise fatigue, metabolic improvement, fat burning or lipolysis) having a possibility of affecting test results. 4) Males who excessive alcohol intake. 5) Male who may interfere with the operation of the test due to allergic rhinitis. 6) Males who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study. 7) Males who have smoking habit. 8) Males who are severe anemia 9) Males who have previous medical history of drug and/or food allergy. 10) Males who donated over 200mL blood and/or blood components within the last one month to this study. 11) Males who donated over 400mL blood and/or blood components within the last three months to this study. 12) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 13) Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiration quotient

Secondary Outcome Measures

Name	Time	Method
Fat oxidation Energy expenditure Skin surface temperature of back Incidence of adverse events and of side effects